These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7858417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM.
    J Immunol; 1993 Sep 01; 151(5):2667-75. PubMed ID: 8360485
    [Abstract] [Full Text] [Related]

  • 4. [Growth inhibition of melanoma cells by interferons in vitro. Similar antiproliferative effects of 100-1000 times lower concentrations of nIFN-beta in comparison with rIFN-alpha-2a].
    Zouboulis C, Garbe C, Orfanos CE.
    Hautarzt; 1989 Feb 01; 40(2):65-9. PubMed ID: 2714987
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
    Richtig E, Soyer HP, Posch M, Mossbacher U, Bauer P, Teban L, Svolba G, Wolf IH, Fritsch P, Zelger B, Volc-Platzer B, Gebhart W, Mischer P, Steiner A, Pachinger W, Hintner H, Gschnait F, Rappersberger K, Pilarski P, Pehamberger H, European Cooperative Adjuvant Melanoma Treatment Study Group.
    J Clin Oncol; 2005 Dec 01; 23(34):8655-63. PubMed ID: 16260701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines.
    Nordenberg J, Perlmutter I, Lavie G, Beery E, Uziel O, Morgenstern C, Fenig E, Weizman A.
    Int J Oncol; 2005 Oct 01; 27(4):1097-103. PubMed ID: 16142328
    [Abstract] [Full Text] [Related]

  • 14. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H, Komura S, Ohishi N, Akiyama S, Kasai Y, Ito K, Nakao A, Yagi K.
    Anticancer Res; 2001 Oct 01; 21(5):3301-6. PubMed ID: 11848487
    [Abstract] [Full Text] [Related]

  • 15. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ, Borden EC, Kalvakolanu DV.
    Clin Cancer Res; 1997 Jun 01; 3(6):931-7. PubMed ID: 9815768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A.
    Br J Cancer; 2001 Sep 01; 85(5):741-6. PubMed ID: 11531261
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.